Medical Cannabis

Delta Pharma Solutions utilize cannabis extract to produce health-oriented products that have low side effects for various treatments. These include:

• Epilepsy
• Multiple Sclerosis
• Diabetes
• Spinal Cord Injury
• Schizophrenia
• Depression
• Sleep Disorders
• Chemotherapy Side Effects

Start your wellness journey with us. Because finding relief is an essential part of living and we're here to help provide the solutions you need to achieve your comfort.

Great News For Medical Cannabis!

Pfizer has entered the medical cannabis industry by acquiring clinical-stage company, Arena Pharmaceuticals, for $6.7 billion. They're betting on a cannabinoid-based bowel disease treatment which has great potential to capture the market and benefit customers worldwide. Under the agreement terms, Pfizer acquires all shares for $100 per share in an all-cash transaction.

The cannabinoid-based drug is designed to treat visceral pain associated with gastrointestinal disorders. This compound, through its selectivity for CB2 versus CB1, is under research and testing for pain relief without psychoactive adverse effects. As more big pharmaceutical companies such as Pfizer seek interest in the cannabis industry, we anticipate rapid growth and continuous R&D on cannabinoids. As more exciting research results and treatment applications become more available, we will have access to the products and will be able to offer them to our clients in the near future. Stay tuned!